Company / R&D per Share
IONIS PHARMACEUTICALS INC R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$5.80
FY2025
5-year range
$3.29 / $6.33
FY2021-FY2025
Trend
-7.2%
vs FY2024
Sector context
#27 of 208
Health Care
What the data says
IONIS PHARMACEUTICALS INC's r&d per share of $5.80 is higher than 87% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 9 years, ranging from $2.70 in FY2019 to $6.33 in FY2023.
Based on SEC 10-K filings.
5.80 in FY2025 with a 5-year CAGR of +14.6%. Top quartile in the Health Care sector.
Declined from $6.33 to $5.80 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +14.6%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 208This company $5.80 Sector average $12.19
▼
-52.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 7.2% year-over-year.
- Ranks #27 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.80 | -7.2% |
| FY2024 | $6.25 | -1.4% |
| FY2023 | $6.33 | - |
| FY2022 | - | - |
| FY2021 | $3.29 | +12.0% |
| FY2020 | $2.94 | +8.7% |
| FY2019 | $2.70 | -0.8% |
| FY2018 | $2.72 | -11.1% |
| FY2017 | $3.06 | +8.3% |
| FY2016 | $2.83 | +4.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026